Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

NRG-LU005, Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab (260043)


Collapse Overview 
Collapse sponsor award id
PROTOCOLNRG-LU005


Collapse Biography 

Collapse Time 
Collapse start date
2019-11-15